However, we still detected an increase in TEMRA cells, but only in the most cytotoxic CD8+CD56+ subset in patients with moderate COVID-19 compared with healthy donors, and there was also a trend towards an increase in TEMRA cells in the ICU group (Figure 2g). Here, NCAM1 is linked to COVID-19.